Skip to main navigation Skip to search Skip to main content

Characterizing the quick-killing mechanism of action of azithromycin analogs against malaria parasites

  • Emma Y. Mao
  • , William Nguyen
  • , Gouranga P. Jana
  • , Bikash C. Maity
  • , Samuel Pazicky
  • , Carlo Giannangelo
  • , Janette Reader
  • , Mufuliat T. Famodimu
  • , Lyn Marie Birkholtz
  • , Michael J. Delves
  • , Darren J. Creek
  • , Zbynek Bozdech
  • , Benoît Laleu
  • , Jeremy N. Burrows
  • , Brad E. Sleebs
  • , Maria R. Gancheva
  • , Danny W. Wilson
  • Adelaide University
  • ARC Training Centre for Environmental and Agricultural Solutions to Antimicrobial Resistance (CEA StAR)
  • Walter and Eliza Hall Institute of Medical Research
  • University of Melbourne
  • TCG Lifesciences Private Limited
  • Nanyang Technological University
  • Monash University
  • University of Pretoria
  • London School of Hygiene and Tropical Medicine
  • ICC
  • Burnet Institute

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

Drug resistance is steadily undermining the efficacy of frontline anti-malarials, highlighting the urgent need for novel therapies with alternative mechanisms of action. The chemical addition of different moieties to azithromycin yields compounds with improved quick-killing potency against malaria parasites, with the most active analogs typically containing a chloroquinoline group. Here, we investigated the quick-killing mechanism of five azithromycin analogs, two of which contain differentially oriented chloroquinoline moieties. The improvement in quick-killing activity over azithromycin for non-chloroquinoline analogs was around 10 -to 42-fold, with chloroquinoline-containing analogs showing a further 2- to 17-fold improvement over non-chloroquinoline compounds. Chemical inhibition of hemoglobin digestion and chloroquine’s inhibitory effect against heme polymerization linked analogs with both chloroquinoline and non-chloroquinoline modifications to a chloroquine-like mechanism of action. However, none of the analogs showed a significant reduction in efficacy against chloroquine-resistant asexual blood-stage parasites. Multiple attempts at selecting for azithromycin analog-resistant parasites to elucidate the mechanism of quick-killing were unsuccessful. Application of cellular thermal shift proteomics revealed that azithromycin analogs significantly stabilized 34–155 different proteins in trophozoites, a high number that showed minimal overlap with chloroquine. Additionally, our most potent chloroquinoline-containing analog demonstrated a significant improvement in gametocytocidal activity over azithromycin and further maintained moderate inhibition of chloroquine-insensitive late-stage gametocytes. These findings support that this class of azithromycin analogs kills malaria parasites through a broad range of potential mechanisms, making them promising candidates for optimization as fast and broad-acting anti-malarials.

Original languageEnglish
JournalAntimicrobial Agents and Chemotherapy
Volume69
Issue number9
DOIs
Publication statusPublished - 25 Jul 2025
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • antimalarial agents
  • azithromycin
  • cellular thermal shift assay
  • malaria
  • Plasmodium

Fingerprint

Dive into the research topics of 'Characterizing the quick-killing mechanism of action of azithromycin analogs against malaria parasites'. Together they form a unique fingerprint.

Cite this